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Modulation of intracellular chloride concentration
([Cl]i) plays a fundamental role in cell volume regula-
tion and neuronal response toGABA. Cl exit via K-Cl
cotransporters (KCCs) is a major determinant of
[Cl]I; however, mechanisms governing KCC activi-
ties are poorly understood. We identified two sites
in KCC3 that are rapidly dephosphorylated in hypo-
tonic conditions in cultured cells and human red
blood cells in parallel with increased transport ac-
tivity. Alanine substitutions at these sites result in
constitutively active cotransport. These sites are
highly phosphorylated in plasma membrane KCC3
in isotonic conditions, suggesting that dephosphory-
lation increases KCC3’s intrinsic transport activity.
Reduction of WNK1 expression via RNA interference
reduces phosphorylation at these sites. Homologous
sites are phosphorylated in all human KCCs. KCC2 is
partially phosphorylated in neonatalmouse brain and
dephosphorylated in parallel with KCC2 activation.
These findings provide insight into regulation of
[Cl]i and have implications for control of cell volume
and neuronal function.
INTRODUCTION
The establishment, maintenance, and modulation of the intracel-
lular milieu play critical roles in diverse biological functions. One
example is the dynamic regulation of intracellular Cl concentra-
tion ([Cl]i), which plays a vital role in the maintenance of cell
volume and modulation of the neuronal response to GABA.
Without a cell wall, eukaryotic cells face the threat of uncon-
trolled swelling and shrinkage from changes in extracellularosmolarity, which can rapidly result in cell death if unopposed.
Diverse epithelia rigorously defend intracellular volume by
rapidly activating electrolyte transport pathways to change intra-
cellular solute concentration to prevent transmembrane water
flux (Lang et al., 1998). This is primarily achieved by altering
the balance between Cl entry and Cl exit via members of the
SLC12A family of electroneutral cation-chloride cotransporters.
These cotransporters can move Cl with or against its electro-
chemical gradient, using the large transmembrane gradients
for Na+ and K+ (Figure 1). Cl influx occurs via the Na-K-Cl
cotransporter NKCC1 (Lang et al., 1998) while Cl efflux occurs
via the K-Cl cotransporters (KCC1–4) (Adragna et al., 2004;
Gamba, 2005).
The activities of these cotransporters are coordinated and
reciprocally regulated. Phosphorylation activates NKCC1 and
inhibits KCCs, while dephosphorylation has opposite effects
(Dunham et al., 1980; Jennings and Schulz, 1991; Altamirano
et al., 1988; Lytle and Forbush, 1992; Haas and Forbush, 2000;
Adragna et al., 2004) (Figure 1). The modulation of [Cl]i in
response to osmotic challenge is rapid, occurring within minutes
(Lang et al., 1998; Joiner et al., 2007). KCC activation in hypo-
tonic stress is ablated by the phosphatase inhibitor calyculin A,
suggesting an essential role of cotransporter phosphorylation
in the acute response (Adragna et al., 2004). This homeostatic
mechanism is widely conserved in species ranging from Caeno-
rhabditis elegans to humans (Haas and Forbush, 2000; Adragna
et al., 2004; Strange et al., 2006). While specific phosphorylation
sites that account for NKCC1 regulation were identified by inves-
tigation in shark rectal gland, where expression is very high (Lytle
and Forbush, 1992), the low abundance of KCCs has to date
thwarted identification of their presumed regulatory phosphory-
lation sites.
In addition to their roles in cell volume regulation, NKCC1 and
KCC cotransporters play a distinct role in neurons, determining
[Cl]i and the response to g-aminobutyric acid (GABA), the
primary inhibitory neurotransmitter in the central nervous systemCell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc. 525
Figure 1. Chloride Cotransport Mechanisms in Cell Volume Control and Neuronal Response to GABA
Na-K-Cl and K-Cl cotransporters are depicted in a generic cell and neuron; their activities are believed to be reciprocally regulated by phosphorylation.
(A) Hypertonic conditions stimulate cotransporter phosphorylation (P) resulting in active Na-K-Cl cotransport and inactive K-Cl cotransport. Hypotonic conditions
result in dephosphorylation, with inactive Na-K-Cl cotransport and active K-Cl cotransport.
(B) The balance between Na-K-Cl and K-Cl cotransport activities set the [Cl]i in GABAA-positive neurons. [Cl
]i and the membrane potential determines the flux
of Cl in response to GABA. K-Cl cotransport expression increases and Na-K-Cl expression decreases postnatally.(CNS). Binding of GABA to the GABAA receptor opens an asso-
ciated Cl channel, [Cl]i, and the membrane potential deter-
mines the resulting Cl flux, which in turn can modulate the
response to GABA from hyperpolarization (inhibition) to depolar-
ization (excitation). In the adult CNS, high KCC2 levels results in
very low [Cl]i and GABA signaling results in inhibition in most
neurons (Thompson and Ga¨hwiler, 1989; Rivera et al., 1999).
Conversely, in early development, NKCC1 levels are high while
KCC2 activity is low, resulting in high [Cl]i and an excitatory
response (Plotkin et al., 1997; Yamada et al., 2004). In rodent
hippocampus, for example, this developmental switch from
GABA excitation to inhibition occurs in the first week after birth
(Rivera et al., 1999); however, there is heterogeneity in the timing
of this switch (Ben-Ari, 2002). While KCC2 levels change in this
time period, it is not clear that expression level alone, versus
altered regulation of transporter activity, explains the increase
in KCC2 activity. Similarly, some neurons in the adult, such as
those in the suprachiasmatic nucleus, dynamically modulate
[Cl]i and the response to GABA cycles from excitatory to inhib-
itory (Wagner et al., 1997). Moreover, prolonged postsynaptic
spiking in mature neurons results in Ca2+-dependent reduction
in KCC2 activity, thereby reducing the inhibitory effect of
GABA, which also occurs in a time frame not likely mediated
by altered gene expression (Fiumelli et al., 2005). Finally, genetic526 Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc.deficiency for KCC2 in mouse is postnatal lethal owing to distur-
bances in [Cl]i (Hu¨bner et al., 2001).
In addition, K-Cl cotransport activity is prominent in reticulo-
cytes and represents the major volume-sensitive cation trans-
port mechanism in human erythrocytes (Brugnara and Tosteson,
1987; Brugnara et al., 1993). In sickle cell anemia, increased KCC
activity results in increased Hb concentration, promoting Hb S
polymerization (Brugnara et al., 1986; Eaton and Hofrichter,
1990; Lew and Bookchin, 2005; Joiner et al., 2007).
Efforts to identify regulatory sites on KCCs have heretofore
been hampered by technological challenges that may be over-
come by recent advances. Recently developed matrices such
as titanium dioxide (TiO2) can quantitatively bind and enrich
phosphopeptides (Pinkse et al., 2004; Bodenmiller et al.,
2007). Similarly, monitoring quantitative changes in phosphory-
lation has advanced with stable isotope labeling of amino acids
in cell culture (SILAC) and multiple reaction monitoring (MRM),
allowing direct comparison and precise quantitation of phospho-
peptide levels in different experimental conditions (Ong et al.,
2002; Olsen et al., 2006; Wolf-Yadlin et al., 2007).
Using these technologies, we now report the identification of
two key phosphorylation sites, conserved among all KCC iso-
forms, which regulate KCC activity and are modulated across
development and by physiologic perturbation.
Figure 2. Identification of Phosphorylation Sites in KCC3
(A) Phosphorylation site mapping. Myc-tagged human KCC3 was purified and
digested with trypsin and phosphopeptides were enriched on TiO2 and sub-
jected to LC-MS/MS.
(B) Representative MS/MS spectrum. Assignment of the peptide VHMTPWTK
(TP1048) is shown. The phosphorylated precursor ion, 491.7 +2, was selected
and produced the fragment ion spectrum shown. Specific y and b fragment
ions allowed unambiguous identification of the precursor peptide and
phosphorylation at T1048. Fragment ions with neutral loss of phosphate
(Py4, Pb4, etc.) are indicated.RESULTS
Identification of KCC3 Phosphorylation Sites
We made a stable HEK293 cell line with tetracycline-regulated
expression of human myc-tagged KCC3 inserted into a defined
site in the genome as a single copy (HEK-KCC3tetON). Clonal cell
lines with tetracycline-inducible expression of KCC3 showed
low levels of endogenous KCC activity, and transgenic KCC3
activity, as measured by 86Rb uptake, showed the expected
properties of tetracycline dependence, marked stimulation by
extracellular hypotonicity, chloride dependence, sensitivity to
2 mM furosemide, and ablation of hypotonic stimulation by the
phosphatase inhibitor calyculin A (see Figures S1 and S3 avail-
able online; data not shown).
To map phosphorylation sites on KCC3, we used phospho-
peptide enrichment coupled to LC-MS/MS. KCC3 was purified
by immunoprecipitation (IP) using anti-myc antibodies followed
by SDS-PAGE, digested with trypsin, and applied to a matrix
of TiO2 (Figure 2A; Pinkse et al., 2004). Both TiO2-bound and
unbound fractions were separated on a C18 reverse phase
nano-HPLC column and directly injected into an ESI-QTOF
mass spectrometer.
From the MS/MS results, KCC3 phosphopeptides and non-
phosphopeptides were identified using the Mascot database
search algorithm, verified by manual inspection of the spectrum
(Figure 2B) (Perkins et al., 1999). Peptides from the TiO2-bound
and unbound fractions covered 77% of the amino acids of
the N terminus and 59% of the C terminus of KCC3, including
65% of the serine and threonine residues in these segments.
In contrast, we recovered only a small fraction of peptides
from the remainder of the protein, which is highly hydrophobic
with 12 predicted transmembrane domains (Figure S2 and
Table S1).
In three mapping experiments we reproducibly observed the
quantitative enrichment on TiO2 of five phosphopeptides, with
no phosphopeptides in the unbound fraction (Figures 2B and
2C and Table S1). All of these phosphopeptides and the sites
of phosphorylation were unambiguously assigned from the
precise match of the m/z ratio of observed peptide precursor
ions and their fragment ions to those predicted to result from
trypsin cleavage of KCC3. Phosphorylation sites were assigned
from fragment ions bearing either the phosphate group itself or
the signature of neutral loss of H3PO4 (98 Da) (Figure 2B).
Reduced Phosphorylation of T991 and T1048
in Hypotonic Conditions
Because dephosphorylation is believed to be a key step in the
activation of KCCs in response to cell swelling (Jennings and
Schulz, 1991), we determined whether phosphorylation at any
of these sites changes in response to extracellular hypotonicity
using SILAC (Ong et al., 2002; Olsen et al., 2006), which permits
direct comparison of phosphopeptide abundance in isotonic
(C) Identified phosphorylation sites in KCC3. The topology of KCC3 is depicted
and identified phosphorylation sites are indicated in red; the phosphopeptides
identified are shown numbered as in human KCC3a (GeneID 9990). All KCC3
peptides observed are listed in Table S1.Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc. 527
and hypotonic conditions. HEK-KCC3tetON was grown in either
normal (‘‘light’’) medium or ‘‘heavy’’ medium containing 13C-
and 15N-labeled arginine (+10 Da) and 13C-labeled lysine (+6 Da).
The cells in heavy and light media were then exposed for 5 min to
either isotonic (310 mOsm) or hypotonic (190 mOsm) medium,
respectively (Figure 3A). Cells from each condition were lysed
and mixed together; KCC3 was purified and applied to TiO2
columns, and peptides bound to TiO2 were quantitated by
tandem MS following careful evaluation of the precursor ion
spectra to ensure proper identification of each m/z peak of
interest. The identities of all SILAC pairs were confirmed by
identification of their fragment ions from MS/MS data. The
heavy/light peptide ratios were obtained from the intensity of
the first monoisotopic m/z peak of each precursor ion pair
(Figure 3B).
In addition to the seven phosphopeptides queried (two phos-
phopeptides were recovered with both oxidized and unoxidized
methionines), six acidic nonphosphorylated peptides of KCC3
Figure 3. SILAC Analysis of KCC3 Phos-
phorylation Dynamics in Hypotonic Stress
(A) Schematic of SILAC experiment. HEK-
KCC3tetON were labeled with either ‘‘light’’ or
‘‘heavy’’ arginine and lysine and exposed for
5 min to either hypotonic or isotonic medium.
Lysates from the two conditions were mixed and
processed for identification of phosphopeptides.
(B) Representative MS spectra of SILAC pairs. The
precursor ion spectra of nonphosphopeptide
E165-K176+2 (SILAC pair 693.3/696.4) and the
phosphopeptides I22-R38+2 (SILAC pair 934.2/
939.3), T991-R977+2 (SILAC pair 494.7/499.7),
and V1045-K1051+2 (SILAC pair 491.7/494.7) are
shown. All SILAC pairs used for quantitation are
listed in Table S1. Green arrows for control
peptides and red arrows for phosphopeptides
denote the peaks used for quantitation.
(C) The ratio of light to heavy m/z peak intensity
(hypotonic to isotonic) of each peptide is pre-
sented as the mean ± SD of three biological repli-
cates. Peptides are labeled per human KCC3a.
I22-R38 (contains SP32), D1020-R1026 (SP1023),
L1027-K1044 (SP1029), T991-R997(TP991),
V1045-K1051(TP1048).
that quantitatively bind to the TiO2 matrix
served as internal controls for each SILAC
experiment.
The results of three biological repli-
cates are shown in Figure 3C. The six
control KCC3 peptides all gave consis-
tent peptide ratios and there were no
significant differences in the ratio among
different peptides in this group. Compar-
ison of all phosphopeptide ratios to all
nonphosphopeptide ratios by ANOVA
rejected homogeneity of all phosphopep-
tides and nonphosphopeptides (p <
0.001). Examination of the individual pho-
sphopeptide ratios revealed that two
phosphopeptides, bearing phosphorylation at T991 and T1048,
showed significantly and reproducibly reduced phosphorylation
in hypotonic conditions (35% reduction, p = 0.00005, and 33%
reduction, p = 0.00008, versus nonphosphopeptide controls,
respectively). Both the methionine-oxidized and nonoxidized
forms of each of these two peptides showed reduced phosphor-
ylation.
Dephosphorylation at T991 and T1048 Cooperatively
Activate KCC3
The loss of phosphorylation at T991 and T1048 in hypotonic
conditions suggests that dephosphorylation at these sites might
be sufficient for activation of KCC3. We substituted alanine for
threonine at these positions and also at S1023 as a control. These
mutations were produced alone and in all possible pairwise
combinations and were introduced into HEK293 cells as single
copy transgenes and two independent clones of each mutant
were studied. We induced expression of transgenic KCC3 and528 Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc.
Figure 4. Alanine Substitutions at T991 and
T1048 Cooperate to Activate KCC3
KCC3’s harboring-indicated substitutions were
engineered into HEK-KCC3tetON and expressed
and cells were exposed to 86Rb in isotonic condi-
tions.
(A) An autoradiogram showing 86Rb uptake in cells
in three individual wells demonstrates an increase
in 86Rb uptake in the T991A and T1048A single
mutants and a dramatic increase in the T991A/
T1048A double mutant.
(B) 86Rb uptake in WT and mutant HEK-KCC3tetON
cells under isotonic conditions was quantitated
and compared to values in WT cells exposed to
hypotonic conditions. Mean ± SD of six indepen-
dent flux experiments for each construct are
shown for this panel and (C) and (D).
(C) 86Rb flux assays in hypotonic conditions with
and without calyculin A. The T991A and T1048A
cell lines show further activation by hypotonic
conditions (*p % 0.00003 versus wild-type (WT)
flux in isotonicity; **p % 0.00001 for hypotonic
versus isotonic conditions in each cell line;
***p % 0.00004 for the presence versus absence
of calyculin A in hypotonicity in each cell line).
(D) The KCC3 T991A/T1048A double mutant (as-
sayed as in C) is highly active in isotonicity (note
change in scale compared to C), shows no further
activation in hypotonic conditions, is insensitive to
calyculin A (+CalA), and is inhibited by Furosemide
(+Furo).
(E) Conservation of T991 and T1048 in KCC family
members. The conservation of three phosphoryla-
tion sites is shown in KCC3 orthologues in mouse,
sea squirt (Ciona intestinalis), green puffer fish,
and human KCC1, 2, and 4. While S1023 is not
conserved, T991, T1048, and their surrounding
sequences are conserved among these and 31
other chordate KCCs (Acc# TF313657; http://
www.treefam.org; Li et al., 2006).assayed the resulting KCC-dependent 86Rb uptake. KCC3 con-
taining the single substitutions T991A or T1048A each showed
highly significant increases in activity (4- to 5-fold, p % 3 3
109) in isotonic conditions in which the wild-type (WT) cotrans-
porter shows little activity (Figures 4A and 4B). These activities
are similar to those seen with hypotonic activation of the WT
cotransporter (Figures 4B and 4C). In contrast, KCC3 with the
S1023A substitution showed no significant change in activity.
Combining either T991A or T1048A with S1023A showed no
further increase in activity. However, combination of the T991A
and T1048A substitutions resulted in a dramatic increase in
KCC3 activity in isotonic conditions that was 25-fold greater
than activity of the WT cotransporter in isotonic conditions (p <
3 3 1010; Figures 4A–4D). This activity was markedly greater
than expected from simple additive effects of each mutant alone.
Not surprisingly, cells expressing this constitutively active KCC3
become shrunken in isotonic conditions and begin to die if
expression is maintained more than 16 hr (data not shown).Exposure of cells with either the T991A or T1048A mutations to
hypotonic conditions resulted in further increases in KCC activity
(Figure 4C), suggesting that hypotonicity results in further
dephosphorylation at the nonmutated site. Supporting this inter-
pretation, KCC3 harboring both the T991A and T1048A substitu-
tions does not increase activity in hypotonic conditions (Fig-
ure 4D), suggesting that no additional sites are involved in
activation of cotransporter function.
The activation of KCCs in hypotonic conditions is mediated by
protein phosphatases and is inhibited by calyculin A (Adragna
et al., 2004). If the normal targets of these phosphatases are
constitutively dephosphorylated (e.g., by mutation to alanine),
calyculin A should be incapable of reverting KCC3 activation.
The T991A/T1048A double mutant showed insensitivity to caly-
culin A (Figure 4D). Moreover, while the single mutant T991A
could not be inhibited by calyculin A, the T1048A mutant was
strongly inhibited (Figure 4C). These results suggest that TP991
is the major target of the phosphatase inhibited by calyculin A.Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc. 529
Conservation of KCC3 Phosphorylation Sites
and Candidate Kinases
Because hypotonic activation of KCCs is highly conserved (Adra-
gna et al., 2004; Gamba, 2005), we evaluated the conservation of
the identified phosphorylation sites and their contexts across
31 KCCs from 11 chordate species. Only T991 and T1048 are
completely conserved in all orthologues and paralogues and lie
in sequence motifs that are also highly conserved (Figure 4E).
To determine whether these identified phosphorylation sites
correspond to known kinase specificities, we used PHOSIDA
and NetworKIN algorithms (Olsen et al., 2006; Gnad et al.,
2007). Interestingly, motifs at the highly conserved sites T991
and T1048 do not correspond to the specificity of any known
kinase.
To determine whether the sites homologous to T991 and
T1048 are phosphorylated in other KCC members, we devel-
oped antibodies specific for peptides that are phosphorylated
at T991 and T1048 in KCC3 (Figure 5A). Signals from each phos-
phoantibody were specific, as they were abolished by treatment
with alkaline phosphatase, phosphatase PP1A, or alanine
substitution at these positions (Figure 5A). Because of the high
degree of conservation of the immunizing peptide, these anti-
bodies also recognize homologous phosphopeptides in human
KCC1, 2, and 4; expression of these epitope-tagged KCCs fol-
lowed by IP and western blotting show that KCC1, 2, and 4 are
all phosphorylated at sites homologous to T991 and T1048
(Figure S3).
Hypotonicity Induces Dephosphorylation of KCC3
in Red Blood Cells
If T991 and T1048 play a role in the regulation of KCC3 in vivo,
they should be phosphorylated in cells in which these cotrans-
porters are inactive and dephosphorylated in conditions in which
they are active.
Red blood cell KCC3 is maintained in a largely inactive state
unless activated by hypotonic conditions. We purified native
KCC3 and analyzed phosphopeptides by mass spectrometry
(Figure 5B). We observed phosphorylation at both T991 and
T1048 (Figure 5B and Table S2).
We next examined KCC3 phosphorylation dynamics in
response to hypotonicity. Western blotting of KCC3 purified
from red cells incubated in isotonic or hypotonic conditions
demonstrated a reduction in phosphorylation at each site in
response to hypotonicity. Quantitation of these signals in multiple
biological and technical replicates suggests 40% reduction in
phosphorylation at each site (Figure 5C), consistent with results
in HEK293 cells.
Dephosphorylation of Regulatory Sites Activates KCC3
Already Present at the Plasma Membrane
These findings raise the question of whether dephosphorylation
increases the intrinsic transport activity of KCC3 that is already
present at the plasma membrane or, alternatively, whether
dephosphorylation is the trigger for translocation of KCC3 to
the cell surface. To address this question we biotinylated cell
surface proteins in KCC3-expressing HEK293 cells grown in
isotonic conditions, purified biotinylated and nonbiotinylated
fractions, and performed western blotting (Figure 6A). The530 Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc.results demonstrate that a large fraction of KCC3 is present at
the plasma membrane in isotonic conditions and that this frac-
tion is in fact enriched for KCC3 phosphorylated at T991 and
T1048. These findings demonstrate that dephosphorylation is
not required for KCC3 to reach the plasma membrane and
supports a mechanism in which dephosphorylation increases
KCC3’s intrinsic transport activity.
Figure 5. Phosphorylation of T991 and T1048 in KCC3 from Human
Red Blood Cells and Response to Hypotonicity
(A) KCC3 phosphorylation detected via phosphospecific antibodies. WT myc-
tagged KCC3 was purified and subjected to western blotting using antibodies
specific for TP991 or TP1048 before and after treatment with alkaline phospha-
tase (AP), with PP1A, or in the presence of the T991A or T1048A substitutions.
Blots were stripped and reprobed for total KCC3 with anti-myc antibodies.
(B) Endogenous KCC3 was purified from human red blood cells and phospho-
peptides were identified after TiO2 enrichment. A representative MS/MS spec-
trum from the phosphopeptide-containing TP991 (precursor ion 502.7+2) is
shown. The precursor ion (+PM+2) and the ion derived from neutral loss of
the phosphate (PM+2) are observed (red spectra); other fragment ions
(y and b ions) observed at lesser intensity in the same spectrum (black spec-
trum amplified 16-fold) confirm the identity of the precursor ion.
(C) KCC3 phosphorylation dynamics in response to hypotonic conditions.
Human red blood cells were incubated in isotonic or hypotonic medium,
KCC3 was isolated, and the level of KCC3 phosphorylation at TP991 and
TP1048 from each treatment group was visualized by western blot using phos-
phospecific antibodies. The results show reduced phosphorylation at T991
and T1048 after exposure to hypotonic conditions.
Figure 6. Localization, Dynamics, and Quantitation of KCC Phosphorylation In Vivo
(A) Western blot analysis of cell surface KCC3 in HEKtetON cells. After cell surface biotinylation, biotinylated (R) and nonbiotinylated (FT) KCC3 proteins were puri-
fied. Equal volumes of each sample were compared on parallel blots and probed with antibodies to total (aKCC) or phospho-KCC3 (aTP991 and aTP1048). Phos-
phorylation at TP991 and TP1048 is greater in the surface pool of KCC3.
(B) MRM of KCC3 peptides from the HEKtetON cell surface. MRM of the KCC3 peptides TPLMMEQR (m/z 494.7+2) and TLMMEQR (m/z 454.7+2) were selected and
y4 fragment ions (m/z 563.3+1 for each) were monitored. The extracted ion chromatograms of the native peptides and their corresponding internal standards are
shown.
(C) Quantitation of KCC phosphorylation. Total phosphopeptide and nonphosphopeptide were calculated from the concentration curve obtained via MRM from
the heavy labeled peptides (Figure S5). The mean and standard deviations are plotted for percent phosphorylation at the indicated site and were derived from
quantities calculated from three separate fragment ions from each peptide.
(D) In vivo phosphorylation and developmental dynamics of mouse brain KCC2. MRM of a nonphosphorylated KCC2 peptide, NFIELVR (m/z 445.8+2), from equal
amounts of KCC2 protein at four developmental time points. Two fragment ions, m/z 516.3+1 and 629.4+1, were monitored. Extracted ion chromatograms for
these two fragment ions are shown, showing little difference in the amount of peptide across these time points.
(E) MRM of the KCC2 peptide TPLVMEQR. The precursor ion TPLVMEQR, m/z 478.7+2, was selected. Three fragment ions, m/z 563.3+1, 662.3+1, and 775.4+1,
were monitored and their extracted ion chromatograms are shown, demonstrating nearly complete loss of all transitions of this phosphopeptide at later devel-
opmental stages.Stoichiometry of Phosphorylation at Regulatory Sites
If KCC3 is present but inactive at the cell surface in isotonic
conditions, these sites should be phosphorylated with high stoi-
chiometry. MRM permits determination of the absolute stoichi-ometry of phosphorylation at these sites by introducing known
amounts of heavy isotope-labeled synthetic peptides corre-
sponding to their phosphorylated and nonphosphorylated
versions, generating a standard curve, and then quantitatingCell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc. 531
the experimentally observed amounts of each peptide. We puri-
fied cell surface-biotinylated KCC3 from HEK293 cells and KCC3
from human red blood cell ghost membrane preparations main-
tained in isotonic conditions and performed MRM. Consistent
with expectations, the results demonstrate 89% phosphoryla-
tion at T991 and 42% phosphorylation at T1048 in HEK293 cells
and 91% phosphorylation at T991 and 65% at T1048 in human
red blood cells (Figures 6B and 6C).
Modulated Phosphorylation and Activity of KCC2
in Mouse Brain Development
Unlike red cell KCC3, which is inactive and highly phosphory-
lated at T991 and T1048 under basal conditions, neuronal
KCC2 is normally highly active in adult brain, but there is little
KCC2 activity in neonatal brain. We consequently would expect
to find low phosphorylation of KCC2 in adult brain and higher
phosphorylation in neonatal brain (accepting that additional
factors such as lower gene expression in neonatal brain also
play a role; Rivera et al., 1999). We purified endogenous KCC2
from mouse brain at P0 (the day of birth) and searched for
KCC2 phosphopeptides and nonphosphopeptides by TiO2 and
MS/MS as above. At P0 we detected phosphorylation at posi-
tions T906 and T1006, homologous to the regulatory sites in
KCC3 (Table S2 and Figure S5). In contrast, interrogation of
these same two sites in adult brain showed no evidence of phos-
phorylation by this method.
To quantitate this developmental change, we performed MRM
without TiO2 enrichment. Equal amounts of KCC2 from different
developmental time points (P0, P3, P21, and adult brain) were
analyzed for phosphorylation at T906 and compared to levels
of a nonphosphorylated control peptide and nonphosphorylated
T906 (Figures 6D, S4, and S5). Phosphorylation at T906 was
progressively reduced with time, with a 33% reduction by P3
and >90% reduction at P21 and adult (Figures 6C–6E and S4).
These results were statistically significant and reproducible in
biological replicates.
While regulatory phosphorylation sites are conserved in KCC2,
this alone does not establish that their modulation regulates
KCC2 activity. To test this, we introduced either WT human
KCC2 or KCC2 in which the threonine at positions 906 and
1007 have been substituted with alanine into HEK293 cells and
measured the resulting KCC-dependent 86Rb uptake in isotonic
conditions. Similar to KCC3, KCC2 with these alanine substitu-
tions showed a 4-fold increase in activity compared with WT
KCC2 (Figure S6). This finding establishes that phosphorylation
of these sites regulates activity of both KCC2 and KCC3 and
strongly suggests that modulation of phosphorylation at the
conserved sites in KCC1 and 4 will modulate their activities
as well.
MRM experiments were also performed to measure absolute
stoichiometry of phosphorylation at T906 in KCC2 from mouse
brain at different developmental stages (the peptide containing
T1006 in KCC2 could not be assayed due to extremely low ioni-
zation efficiency, a result confirmed by use of synthetic peptides
and MRM). At P0, 18% of KCC2 is phosphorylated at T906. This
fraction is reduced to 9% by P3 and to undetectable levels from
day 21 onward (Figures 6C–6E and S4). Because this stoichiom-
etry represents phosphorylation in the whole brain, this finding532 Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc.cannot distinguish between 18% phosphorylation in each
neuron expressing KCC2 at P0 versus complete phosphoryla-
tion in neurons in some brain regions and complete dephosphor-
ylation in others (or any intermediate models); this consideration
is relevant since regional variation in KCC2 activity has been re-
ported (Ben-Ari, 2002).
WNK1 Is Required for Normal Phosphorylation of T991
and T1048 in KCC3
We have attempted to identify kinases and phosphatases
involved in the modulation of phosphorylation at KCC3 T991
and T1048. We examined the ability of purified protein phospha-
tases PP1, PP2A, PP2B, and DUSP22 to dephosphorylate TP991
and TP1048 in KCC3. Both PP1 and PP2A dephosphorylated
both sites, while the latter phosphatases did not (Figure S3).
The WNK kinases and SPAK/OSR1 are strong candidates for
KCC3 regulatory kinases. The WNK kinases play a role in the
orchestration of activities of the SLC12A family of electroneutral
cotransporters (Kahle et al., 2005; Rinehart et al., 2005; de Los
Heros et al., 2006), and the kinase activity of WNK1 is modulated
by changes in extracellular tonicity (Xu et al., 2000; Wilson et al.,
2001; Strange et al., 2006). Similarly, the kinases SPAK and
OSR1 play a role in modulation of NKCC1 activity (Vitari et al.,
2006). By quantitative PCR of the HEK-KCC3tetON cells, we
found robust expression of WNK1 and SPAK, with lower levels
of OSR1, still lower levels of WNK2, and orders of magnitude
lower expression of WNK3 and WNK4 (data not shown).
We used RNA interference (RNAi) to individually knock down
expression of each of these six genes in HEK-KCC3tetON cells.
For each gene, at least two small-interfering RNA (siRNA)
duplexes that individually produce R75% knockdown of the
target were identified and assayed in at least three biological
replicates. After 24 hr exposure to siRNAs, KCC3 expression
was induced for 16 hr and phosphorylation at T991 and T1048
was examined by western blotting (Figure 7A). siRNAs targeting
KCC3 demonstrated robust knockdown of KCC3 protein,
providing a positive control, and random sequence negative
controls as well as siRNA for the low-level expressed WNK2, 3,
and 4, did not change phosphorylation at T991 and T1048
(Figure 7B). Similarly, knockdown of SPAK and OSR1 had no
significant effect on T991 or T1048 phosphorylation (data not
shown). In contrast, knockdown of WNK1 with either of two
siRNAs reproducibly reduced phosphorylation at both T991
and T1048 (Figures 7C and 7D), implicating WNK1 in the regula-
tion of phosphorylation at these sites.
DISCUSSION
We have identified phosphorylation sites in KCCs that regulate
their activities. High degrees of phosphorylation at these sites
inhibit activity at the plasma membrane and mutations that
prevent phosphorylation at these sites result in dramatic consti-
tutive activation. The physiologic relevance of regulated phos-
phorylation at these sites for the acute response to hypotonic
stress seems clear since both HEK293 and human red blood
cells have high stoichiometric phosphorylation of these site in
isotonic conditions in which KCC activity is low, and these sites
are rapidly dephosphorylated in response to hypotonic stress,
Figure 7. RNAi Targeting of WNK1 Reduces KCC3 Phosphorylation
(A) RNAi experimental scheme. siRNAs were introduced into HEK-KCC3tetON cell lines by transient transfection. KCC3 expression was induced 24 hr later, lysates
were harvested after 16 hr, and KCC3 phosphorylation was examined by western blot with phosphoantibodies for TP991 and TP1048.
(B) Experiments with control siRNAs and siRNAs targeting KCC3 are shown and demonstrate stability of negative controls and utility of positive controls.
(C) Quantitative PCR assays of WNK1 expression. WNK1 transcripts were assayed via gene-specific TaqMan reagents and show specific knockdown in
the presence of WNK1 siRNAs (mean and standard deviation of six replicate experiments for each group; the WNK1 siRNA group is pooled data from the
two different siRNAs used).
(D) Reduced phosphorylation at T991 and T1048 after reduction of WNK1 expression. Lysates from HEK-KCC3tetON cell lines transfected with WNK1-specific or
control siRNA were analyzed for phosphorylation at T991 and T1048 by western blotting. The percentage of reduction in WNK1 expression in each experiment is
indicated for biological replicate experiments and the results of western blotting using two different WNK1 siRNAs are shown. The results demonstrate reduced
phosphorylation at T991 and T1048 after WNK1 knockdown.paralleling induction of transport activity. In developing brain, the
phosphorylation state of KCC2 parallels KCC2 activity, with
virtually complete dephosphorylation in adult, where KCC2
activity is maximal. This observation suggests that modulated
phosphorylation at these sites may play a role in regulation of
[Cl]i in GABA-responsive neurons, complementing other regu-
latory mechanisms such as protein turnover and gene expres-
sion (Rivera et al., 2004; Lee et al., 2007); nonetheless, further
work will be required to directly assess the physiologic role of
KCC2 phosphorylation.
These findings provide insight into the regulation and modula-
tion of [Cl]i by KCCs and highlight the ability of targeted quan-
titative phosphoproteomics to provide important insight into bio-
logical regulation as well as biomarkers and reagents to probe
and assess functional states. Measurement of phosphorylation
at these sites may prove a useful biomarker for assessing the
state KCC3; for example, increased KCC3 activity is believed
to contribute to sickle crisis in patients with sickle cell anemia.
Moreover, these findings provide a means for producing consti-tutively active KCC3 and it will be of interest to determine the
effects of constitutively active KCC3 expressed in red blood cells
and other tissues in vivo. Similarly, these findings suggest a test-
able mechanism for the acute inhibition of KCC2 activity that has
been observed to occur in response to prolonged post-synaptic
spiking and is believed to be phosphorylation dependent (Fiu-
melli et al., 2005). Finally, it will also be of interest to determine
the correlation of phosphorylation at regulatory sites in KCC2
with response to GABA in brain nuclei that are known to regularly
modulate their response to GABA (Wagner et al., 1997).
These findings provide further opportunities to define both the
upstream signaling pathway that regulates KCCs as well as the
molecular mechanisms of their activation. Knockdown of
WNK1 via RNAi supports a role for this kinase in the maintenance
of phosphorylation at these sites. This could occur either via
direct phosphorylation of KCC3 by WNK1 or via activation of
other kinases that act at these sites. Alternatively, WNK1 could
negatively regulate phosphatase activity, and loss of WNK1
effects would activate the phosphatase that acts at these sites.Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc. 533
The identification of these regulatory sites provides important
tools that will enable elucidation of the signaling pathways that
regulate KCC activities.
The sequence context of T991 is similar to a motif found in the
N terminus of the SLC12A cotransporter NKCC1 and which is
involved in its regulation (Darman and Forbush, 2002; Dowd
and Forbush, 2003; Vitari et al., 2006; Gagnon et al., 2007).
This motif, YXRTP, could be phosphorylated by a single kinase
that positively regulates KCC3 and negatively regulates
NKCC1 (Figure S7), consistent with the expectation that the
same kinase might have opposing effects on the Cl entry and
exit steps. Systematic mutagenesis of these sites in KCC3 and
NKCC1 and assessment of the resulting transport activities will
be required to assess this possibility.
The presence of two phosphorylation sites that have syner-
gistic effects on KCC activity potentially allows regulation of
KCC activity by different signals as well as modulation of the level
of activity over a wider range than might be achieved by varying
levels of phosphorylation at a single site. The nonadditive effects
of the two sites further raises the question of whether dephos-
phorylation at each site is independent and stochastic or alterna-
tively cooperative, with dephosphorylation at one site promoting
dephosphorylation at the second.
Similarly, the molecular mechanisms that distinguish inactive
from active KCCs have been poorly understood. Our results do
not support a model in which dephosphorylation is required for
translocation of KCC3 to the plasma membrane and instead
suggest that dephosphorylation increases intrinsic transport
activity. As a consequence, our findings should permit testing
of homogenous forms of KCCs in relevant models as either
constitutively active or inactive forms, enabling comparison of
their biochemical and biophysical properties as well as the iden-
tification of proteins that may be physically associated with these
alternative forms.
Finally, these studies also provide tools for probing the phos-
phorylation of these sites and KCC function in vivo. These may
prove relevant to understanding diverse physiologic processes
including cell growth and volume control, normal and abnormal
neuronal and CNS functions, pathophysiology of sickle cell
disease, and electrolyte homeostasis. Further understanding of
the regulation of phosphorylation at these sites may provide
opportunities for their selective modulation for health benefit.
EXPERIMENTAL PROCEDURES
Sources of KCC Proteins
HEK293 Cells
Single copies of WT or mutant human KCC3a cDNAs with an N-terminal myc
epitope expressed under tetracycline control were introduced into HEK293
cells using the Flp-in T-Rex System (Invitrogen). KCC3 was induced at 50%
confluence with tetracycline for 16 hr. Cells were disrupted with a syringe
and narrow gauge needle on ice in the presence of protease and phosphatase
inhibitors in Triton X lysis buffer (TX-LB).
Human Red Blood Cells
Venous human blood was collected from healthy adults, washed, and lysed.
Red cell membrane ‘‘ghosts’’ were prepared by centrifugation and proteins
were extracted with TX-LB and used for IP.
Mouse Brain
Whole mouse brains (P0, six brains; P2, approximately three to four brains; P7,
P21, and adult, two brains per IP) were collected immediately after sacrifice,534 Cell 138, 525–536, August 7, 2009 ª2009 Elsevier Inc.dissected on ice, homogenized in TX-LB, and centrifuged, and the supernatant
was collected and used for IP.
IP and Purification of KCCs
Myc-tagged human KCC3 was purified from HEK-KCC3tetON lysates using
anti-myc antibodies. Native human KCC3 was purified from red cell membrane
preparations using goat anti-KCC3. Native mouse KCC2 was purified from
brain using rabbit anti-KCC2. Protein extracts were mixed with antibodies
and IPs were collected, fractionated by SDS-PAGE, and visualized with
Coomassie blue.
TiO2 Enrichment and LC-MS/MS
Proteins of interest were excised from gels and digested with trypsin. Peptides
were extracted with 0.5% trifluoroacetic acid, dried, resuspended, and applied
to a TiO2 TopTip micro-spin column (Glygen Corp.). Unbound peptides were
washed off and bound peptides were eluted with a 1:33 solution of saturated
ammonia. Protein digests and SILAC experiments were analyzed by LC-MS/
MS. Identified sites of phosphorylation were confirmed using a second spec-
trometer. Spectra were searched with Mascot 2.1 with improved phosphopep-
tide scoring. Phosphopeptide identities were confirmed by manual inspection.
Phosphatase Assays and Immunoblotting
Purified myc-tagged KCC was dephosphorylated by incubation with alkaline
phosphatase, PP1A, PP2A, PP2B, or DUSP22 for 60 min at 30C and sub-
jected to western blotting with anti-myc and phosphospecific antibodies
aTP991 and aTP1048, followed by imaging with ECL reagents (GE Healthcare)
and autoradiography.
Quantitative Comparisons in Cell Cultures with SILAC
SILAC Labeling and Protein Preparation
WT HEK-KCC3tetON cell lines were passaged at 10% confluence in heavy
(L-lysine-13C6, and L-arginine-
13C6
15N4) or light (normal) SILAC media. Cells
were grown to confluence and replated, still in heavy or light medium. KCC3
expression was induced at50% confluence and cells were cultured an addi-
tional 16 hr, after which heavy-labeled cells were incubated for 5 min in isotonic
media while light-labeled cells were incubated for the same time in hypotonic
media . Cells were then lysed in TX-LB as above. Proteins in each lysate were
quantitated (BCA assay; Pierce) and equal amounts from heavy and light
conditions were mixed together. KCC3 expression in each condition was
similar as determined by western blotting. Myc-tagged KCC3 was then puri-
fied via IP as described above.
Quantitative Mass Spectrometry for SILAC
Immunoprecipitated, SILAC-labeled KCC3 proteins were purified and en-
riched with TiO2 as above. SILAC data sets were acquired with LC-MS/MS
as above with additional MASCOT searches to confirm SILAC-derived peptide
pairs. The ratios of the heavy and light tryptic peptides were extracted manu-
ally from the average intensity values of the first monoisotopic m/z peak of all
the mass spectra spanning the LC elution range of interest. All of the precursor
peptide and phosphopeptide m/z values used in ratio determinations were
confirmed to match the sequence of KCC3 by their MS/MS fragment spectra.
Quantitation for each peptide was performed on three biological replicates.
The mean values of the light/heavy intensity ratios of the six control nonphos-
phopeptides were normalized to a ratio of 1.0 and the ratios in phosphopepti-
des were adjusted by the same factor; use of non-normalized data does not
change the significance of the results.
Quantitative Comparisons In Vivo with MRM
LC-MRM was performed using KCC2 from mouse brains of different develop-
mental stages prepared for MS without TiO2 enrichment. Samples were
normalized to provide equal amounts of KCC2 for mass spectrometry. Transi-
tions were selected from MS/MS data and refined with Applied Biosystems
MRMPilot 0.9beta (Table S3). LC-MRM data was processed and quantitated
by calculating the area under the extracted ion chromatogram using Applied
Biosystems Multiquant 1.0 software. Data from Multiquant were exported
and uploaded into the Yale Protein Expression Database (Shifman et al., 2007).
86Rb Uptake Assays
Assays were performed with an automated flux system (Darman and Forbush,
2002). HEK-KCC3tetON cell lines expressing WT or mutant KCC3 proteins were
passaged to 50% confluence, and KCC3 was induced for 16 hr. For the KCC2
studies, the cotransporter was introduced via transient transfection (Lipofect-
amine 2000; Invitrogen) and assayed after 24 hr of protein expression. For flux
assays, the medium was replaced with isotonic or hypotonic medium for 6 min.
Cells were then incubated for 2 min in regular flux media (Darman and Forbush,
2002), washed, dried, and exposed to phosphorimaging plates, scanned with
a GE-Storm Phosphorimaging system, and quantitated with Imagequant soft-
ware. After quantitation, total protein per well was determined. 86Rb uptake
was calculated as pmol/mg/min for each well. For calyculin A pretreatment,
cells were exposed to calyculin A at room temperature for 10 min prior to initi-
ation of the flux experiment. For furosemide inhibition studies, furosemide was
added to the preincubation step and at the flux step.
Erythrocyte Osmotic Stress Studies
Human red blood cells were subjected to hypotonic stress (Joiner et al., 2007).
Washed erythrocyte cell pellets were resuspended in either 320 mOSM
isotonic media or 220 mOsm hypotonic media and incubated for 10 min at
37C. Membranes were then prepared as above. Native KCC3 was immuno-
pecipitated with goat anti-human KCC3. Membrane samples were normalized
by mass and an equivalent amount of antibody per IP was used to ensure
equivalent loading across treatment groups for western blot analysis.
RNAi Studies
siRNAs (Applied Biosystems) were introduced into HEK-KCC3tetON cells via
transient transfection. KCC3 phosphorylation was assayed after 42 hr of
RNAi by western blotting.
Statistical Analysis
The Student’s t test (two-tailed) was used to assess significance of differences
between two groups; ANOVA was used to assess significance of differences
among more than two groups. All experiments were performed at least in bio-
logical triplicate and with a minimum of two technical replicates for each bio-
logical replicate.
SUPPLEMENTAL DATA
Supplemental Data include seven figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)00634-5.
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